FIM+DASH: Food is Medicine Intervention to Promote Healthy Eating and Blood Pressure Control
Part of paid clinical trials in Chicago, Illinois.
- Sponsor
- University of Illinois at Chicago
- Study ID
- NCT07332741
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Hypertension
- Hypertension (HTN)
- Obesity & Overweight
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Interventions
- FIM intervention arm — COMBINATION_PRODUCTFor weeks 1-12: Culinary skill-building: 8 In-person and remote sessions will teach participants core techniques (knife skills, batch cooking, sodium-aware seasoning, whole-grain preparation, vegetable-forward entrées, low fat dairy use, lean-protein methods). DASH-friendly home food delivery. Participants will receive 12 weekly deliveries that provide items consistent with DASH (e.g., fruits/vegetables, low-fat dairy \[lactose-free available\], whole grains, lean proteins) dietary regimen. Participants will receive one-on-one support sessions with the interventionist to reinforce DASH adoption/adherence and HTN self-management tasks. For weeks 13-24, self-monitoring of BP and weight twice monthly continues via the text platform.
- FIM Usual Care Arm — COMBINATION_PRODUCTFIM Usual care arm (control) receives usual clinical care during the 24-week period, with limited study contact outside scheduled data-collection visits; after completing all study visits, control participants receive the post-study materials
Study Details
The goal of this clinical trial is to treat both hypertension and obesity in adults using a food is medicine framework. Participants will be randomized 1:1 to FIM+DASH or usual-care control. The 24-week trial includes a 12-week FIM+DASH intervention followed by a 12-week maintenance period and leverages existing partnerships with community-based organizations for home food delivery and culinary skill-skill building. The main questions it aims to answer are: (1) What is the effect of FIM+DASH vs. usual care control on blood pressure? (2) What is the effect of FIM+DASH vs. usual care control on DASH diet adherence (diet quality), body weight, and waist circumference? (3) How to identify factors associated with the sustainability and scalability of FIM+DASH in real-world settings?
Key Dates
- First listed
- Jan 12, 2026
- Start date
- May 22, 2026
- Status verified
- Sep 2025
- Primary completion
- Jun 30, 2030
- Completion
- Sep 30, 2030
Study Design
- Enrollment
- 150 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Active Comparator: FIM Usual Care ArmParticipants randomized to the usual care arm continue to receive routine clinical care. They do not receive the FIM+DASH intervention during the active intervention period, but they complete study assessments according to the same assessment schedule. If your protocol includes delayed intervention materials/equipment/classes/food support after the primary trial period, include that here.
- Experimental: FIM Intervention ArmParticipants randomized to the experimental arm receive the FIM+DASH intervention, which includes Food is Medicine support aligned with DASH dietary guidance. The intervention includes groceries/food support, cooking/nutrition education, behavioral support, self-monitoring tools, and participant follow-up as specified in the protocol.
Primary Outcome Measure
Systolic and diastolic changes from baseline to 12 weeks and 24 weeks [ Time Frame: Baseline, 12 weeks and 24 weeks ]
Locations (4)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mile Square Health Center - Auburn Gresham | Chicago | Illinois | 60620 | |
| Mile Square Health Center - Englewood | Chicago | Illinois | 60621 | |
| Mile Square Health Center - South Shore | Chicago | Illinois | 60649 | Claire Thesing, MD (SUB_INVESTIGATOR) |
| Mile Square Health Center Chicago | Chicago | Illinois | 60608 |
Find similar trials in Chicago, IL
Related Studies
- A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionPHASE3 · Enrolling By Invitation · United Therapeutics · Phoenix, Arizona
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)Recruiting · Duke University · Little Rock, Arkansas
- Community Intervention to Reduce CardiovascuLar Disease in ChicagoRecruiting · Northwestern University · Chicago, Illinois
- Examining Digital Health Care Delivery Models Through Medicaid CollaborativeRecruiting · OSF Healthcare System · Peoria, Illinois